a Department of Biological Sciences , Towson University , Towson , Maryland , USA.
Nutr Cancer. 2013;65(7):1014-25. doi: 10.1080/01635581.2013.809127. Epub 2013 Oct 2.
Flavonoids are secondary plant products that are well represented in healthy diets because of ingestion of fruit, vegetables, herbs, and teas. Increased consumption is correlated with decreased risks of cardiovascular disease, cancer, and other chronic diseases. Certain flavonoids confer direct antioxidant protection to cells, others induce enzymes that protect cells against oxidative and other insults ("indirect antioxidants"), and others appear to be protective by both mechanisms. Hydroxylated flavones manifest substantial direct antioxidant activity but do not effectively induce cytoprotective enzymes. Methoxylated flavones that potently induce cytoprotective enzymes were evaluated to elucidate the structural prerequisites for effective chemoprotective agents: protecting healthy cells with minimal collateral toxicity. Flavones and flavanones methoxylated at the 5-position of the A-ring were among the most potent inducers of the cytoprotective NAD(P)H:quinone-oxidoreductase 1 (NQO1) in 3 different cell lines. Other flavones were equally potent inducers, but more toxic. Flavanones contain no Michael reaction center, yet some are potent inducers of NQO1, have low cytotoxicity, and inhibit LPS-stimulated iNOS activity, which suggests a redox mechanism of action rather than the Keap1/Nrf2/ARE mechanism by which so many of the classic inducers operate. Evaluation in vivo will reveal whether differential protective advantages support their possible evaluation in a cancer prevention setting.
类黄酮是植物的次生代谢产物,由于水果、蔬菜、草药和茶的摄入,在健康饮食中含量丰富。增加摄入量与降低心血管疾病、癌症和其他慢性病的风险有关。某些类黄酮为细胞提供直接的抗氧化保护,其他类黄酮诱导保护细胞免受氧化和其他损伤的酶(“间接抗氧化剂”),而其他类黄酮似乎通过这两种机制发挥保护作用。羟基黄酮表现出显著的直接抗氧化活性,但不能有效地诱导细胞保护酶。为了阐明有效化学保护剂的结构要求:用最小的附带毒性保护健康细胞,评估了具有强大诱导细胞保护酶能力的甲氧基黄酮。在 3 种不同的细胞系中,A 环 5 位甲氧基化的黄酮和黄烷酮是最有效的细胞保护 NAD(P)H:醌氧化还原酶 1 (NQO1)诱导剂之一。其他黄酮类化合物也是同样有效的诱导剂,但毒性更大。黄烷酮不含迈克尔反应中心,但有些是 NQO1 的有效诱导剂,细胞毒性低,并抑制 LPS 刺激的 iNOS 活性,这表明其作用机制是氧化还原机制,而不是许多经典诱导剂所采用的 Keap1/Nrf2/ARE 机制。体内评估将揭示是否存在差异保护优势,以支持它们在癌症预防中的可能评估。